Investor Relations

Latest Financial Results

Q3 2025

Quarter Ended Sep 30, 2025

Latest Annual Filing

For Year Ending December 31, 2024

Company Overview

Sonim Technologies completed the sale of substantially all of its operating assets to NEXA, a privately held enterprise solutions provider, pursuant to an asset purchase transaction.

The publicly-traded entity was not part of the asset purchase transaction and continues to operate as an independent public company. The Company is currently listed on the Nasdaq stock market under the ticker symbol SONM.

The Company intends to rebrand as DNA X and effect a corresponding name and ticker symbol change. Additional details regarding the transition and public entity are available in the Company’s press release and SEC filings available on this site.

Investor Contact Information

Company

Sonim Technologies Inc.
4445 Eastgate Mall
Suite 200
San Diego, CA 92121
T: 650-378-8100
F: 650-378-8109

Investor Relations

Clay Crolius
clay.crolius@gmail.com